Archive for February, 2008
Anthrax Ruling to Be Appealed - Washington Post
Closed Published by Google Inc. February 29th, 2008 in Google FDA News, Regulatory AffairsEnews 2.0Anthrax Ruling to Be AppealedWashington Post, United States - 7 hours ago… court to block the Pentagon from inoculating the plaintiffs and to rule that the vaccine was improperly licensed by the Food and Drug Administration. …Jud…
US Food and Drug Administration Approves ABILIFY(R) (aripiprazole … - Earthtimes
Closed Published by Google Inc. February 29th, 2008 in Google FDA News, Regulatory AffairsPravdaUS Food and Drug Administration Approves ABILIFY(R) (aripiprazole …Earthtimes, UK - 16 hours ago29 — Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company announced today that the US Food and Drug Administration (FDA) appr…
How Heparin Maker in China Tackles Risks - Wall Street Journal
Closed Published by Google Inc. February 28th, 2008 in Google FDA News, Regulatory AffairsEnews 2.0Baxter Recalls Rest of Heparin ProductsForbes, NY - 1 hour ago"We have assurance from the US Food and Drug Administration that there is an adequate supply in the market to meet the demand for these critical and …Baxter recalls…
Child Studies Make Drugs Safer, Show Laws Work, Researchers Say - Bloomberg
Closed Published by Google Inc. February 28th, 2008 in Google FDA News, Regulatory AffairsKPICGERD Drug Approved for Younger ChildrenForbes, NY - 14 hours ago… disease (GERD) in adults, has been approved for the same short-term use in children ages 1 to 11, the US Food and Drug Administration said Thursday. …FDA OKs Nexium in …
Drug Study Results Hidden by the Food and Drug Administration May … - Web Services Journal
Closed Published by Google Inc. February 28th, 2008 in Google FDA News, Regulatory AffairsDrug Study Results Hidden by the Food and Drug Administration May …Web Services Journal, NJ - 12 hours ago… most negative drug study results are hidden from doctors by the food and drug administration (FDA), leaving doctors in the dark ab…
FDA Approves Nexium for Use in Children Ages 1-11 Years
Closed Published by Food and Drug Administration Press Releases February 28th, 2008 in Regulatory AffairsThe U.S. Food and Drug Administration approved Nexium (esomeprazole magnesium) for short-term use in children ages 1-11 years for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms, a delayed-release capsule and liquid form. Nexium is approved in 10 milligrams (mg) or 20 mg daily for children 1-11 years old compared to 20 mg or 40 mg recommended for pediatric patients 12 to 17 years of age.
FDA Approves New Orphan Drug for Treatment of Rare Inflammatory Syndromes
Closed Published by Food and Drug Administration Press Releases February 27th, 2008 in Regulatory AffairsThe U.S. Food and Drug Administration today approved a drug to help ease the suffering faced by those with certain chronic inflammatory diseases. Arcalyst (rilonacept, an Interleukin-1 blocker) is now approved for the long term treatment of two Cryopyrin-Associated Periodic Syndromes (CAPS) disorders: Familial Cold Auto-Inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).
Biogen, Elan drug liver issues not new - US FDA - Guardian Unlimited
Closed Published by Google Inc. February 27th, 2008 in Google FDA News, Regulatory AffairsRTE.ieBiogen, Elan drug liver issues not new - US FDAGuardian Unlimited, UK - 2 hours ago… Elan Corp Plc's Tysabri drug was added to the label in January and is not a new issue, a US Food and Drug Administration spokeswoman said on Wedn…
Kristalose(R) Offers Prescription Alternative to MiraLAX(R) and … - FOXBusiness
Closed Published by Google Inc. February 27th, 2008 in Google FDA News, Regulatory AffairsKristalose(R) Offers Prescription Alternative to MiraLAX(R) and …FOXBusiness - 5 hours agoDue to US Food and Drug Administration policy which does not allow the same formulation of a product to be marketed simultaneously as both a prescription …
Osiris launches heart disease drug trial - Bizjournals.com
Closed Published by Google Inc. February 26th, 2008 in Google FDA News, Regulatory AffairsOsiris launches heart disease drug trialBizjournals.com, NC - 2 hours agoOsiris (NASDAQ: OSIR) said it received approval for the Phase II trial of Prochymal from the US Food and Drug Administration. …Osiris Stock Up on Heart Drug Study Data…
Antidepressants Only Benefit Certain Depressed Patients, Study … - Science Daily (press release)
Closed Published by Google Inc. February 26th, 2008 in Google FDA News, Regulatory AffairsAl-ArabiyaAntidepressants no better than placebo for most, study saysSydney Morning Herald, Australia - 5 hours ago… drugs known as selective serotonin reuptake inhibitors which had been presented to the US Food and Drug Administration as p…
Chinese drug maker defends plant's safety - Los Angeles Times
Closed Published by Google Inc. February 25th, 2008 in Google FDA News, Regulatory AffairsChinese drug maker defends plant's safetyLos Angeles Times, CA - 4 hours agoBaxter's Chinese supplier, Changzhou SPL — a joint venture with a Wisconsin company — was never inspected by the Food and Drug Administration, …
Ahead of the Bell: Pharmaceutical suits - BusinessWeek
Closed Published by Google Inc. February 25th, 2008 in Google FDA News, Regulatory AffairsAhead of the Bell: Pharmaceutical suitsBusinessWeek - 2 hours agoInstead, it focuses on a specific issue: whether state courts can consider allegations that a drug company misled the Food and Drug Administration to win …
FDA Wants More Power From Congress - Chatter Shmatter
Closed Published by Google Inc. February 24th, 2008 in Google FDA News, Regulatory AffairsMass food poisoning outbreakShanghai Daily, China - 16 hours agoOfficials from Shanghai Food and Drug Administration said victims had eaten lunch and supper provided by Hongyang on Saturday. Employees in other shifts ate …City begins to tra…
More Help for the Heart - Wall Street Journal
Closed Published by Google Inc. February 23rd, 2008 in Google FDA News, Regulatory AffairsMore Help for the HeartWall Street Journal - 5 hours ago… "sufficient scientific evidence" to cover the devices, as long as they are used as part of clinical trials approved by the Food and Drug Administration. …
Search
About
You are currently browsing the Regulatory Affairs Syndicator weblog archives for February, 2008.
Longer entries are truncated. Click the headline of an entry to read it in its entirety.Archives
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- March 2009
- December 2008
- November 2008
- October 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005
- May 2005
- January 2005
- December 1969
Categories
- AAPS PharmSciTech (1)
- AIDS Alert (1)
- Am J Cardiol (1)
- Am J Hosp Pharm (1)
- Am Pharm (1)
- Ann Intern Med (1)
- Ann Pharmacother (2)
- Ann Thorac Surg (1)
- Behav Brain Res (1)
- Biomed Instrum Technol (1)
- Can J Cardiol (1)
- Circulation (1)
- Clin Chem (1)
- Compend Contin Educ Dent (1)
- Congest Heart Fail (1)
- Conn Med (1)
- Consumers (2)
- Contracept Technol Update (1)
- Curr Concepts Hosp Pharm Manage (1)
- Curr Urol Rep (1)
- Dentomaxillofac Radiol (1)
- Drug Intell Clin Pharm (1)
- Expert Rev Med Devices (1)
- FDA Consum (1)
- Fed Regist (8)
- Food Drug Law J (2)
- Food Safety (188)
- Google FDA News (11884)
- Health Devices (2)
- Healthc Hazard Mater Manage (2)
- Heart Rhythm (1)
- Home Healthc Nurse (1)
- Hosp Mater Manage Q (1)
- Hosp Technol Ser (1)
- Hospitals (1)
- Int J Health Serv (1)
- Int J Trauma Nurs (1)
- Int Psychogeriatr (1)
- J Allergy Clin Immunol (1)
- J Am Board Fam Pract (1)
- J Am Coll Dent (1)
- J Am Coll Surg (1)
- J Am Diet Assoc (3)
- J Am Med Inform Assoc (1)
- J Am Pharm Assoc (1)
- J Can Dent Assoc (2)
- J Card Fail (1)
- J Clin Eng (1)
- J Clin Pharmacol (1)
- J Drugs Dermatol (1)
- J Emerg Med (1)
- J Endod (1)
- J Environ Pathol Toxicol (1)
- J Expo Anal Environ Epidemiol (1)
- J Food Prot (1)
- J Healthc Mater Manage (1)
- J Immunol (1)
- J Neural Eng (1)
- J Neurosurg Spine (1)
- J Proteome Res (1)
- J Thorac Cardiovasc Surg (1)
- J Vasc Surg (1)
- JAMA (3)
- Lancet (3)
- Magn Reson Med (1)
- Med Device Technol (6)
- Med Law (1)
- Med World News (1)
- Medical Devices (38)
- MMWR Morb Mortal Wkly Rep (1)
- Mod Healthc (3)
- NIH (354)
- Nippon Hoshasen Gijutsu Gakkai Zasshi (1)
- NY Times (Print) (2)
- OR Manager (1)
- Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1)
- Pa Med (1)
- Pacing Clin Electrophysiol (1)
- Patient Safety (143)
- PDA J Pharm Sci Technol (1)
- Pediatrics (1)
- Public Health Rep (1)
- PubMed Medical Devices (42)
- PubMed Recall (86)
- Purch Adm (2)
- Recalls (202)
- Regulatory Affairs (28975)
- Rev Elev Med Vet Pays Trop (1)
- Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (1)
- Stud Health Technol Inform (1)
- Surg Endosc (1)
- Time (1)
- Transfus Med Rev (1)
- Transfusion (1)
- Uncategorized (4476)
- US News World Rep (1)
- Vaccine (1)
- Value Health (1)
- Women Health (1)
- Yahoo FDA News (8060)
Content Cloud
angeles associated blog blood businessweek cracked diet eggs farms federal feed former found immunogen inspect investigation iowa issues journal largest list meridia press race recall replace report reuters rodents safety salmonella street study times trials view wall warfarin warning york